Thibela TB

Design and methods of a cluster randomised trial of the effect of community-wide isoniazid preventive therapy on tuberculosis amongst gold miners in South Africa

Katherine L. Fielding, Alison D. Grant, Richard J. Hayes, Richard E Chaisson, Elizabeth L. Corbett, Gavin J. Churchyard

Research output: Contribution to journalArticle

Abstract

Background: South Africa has the third highest annual number of new tuberculosis (TB) cases globally. The resurgence of TB which has particularly affected gold miners in South Africa, is attributed to occupational risk factors for TB including silica dust exposure and high HIV prevalence. Isoniazid preventive therapy (IPT) is recommended for individuals at high risk to prevent both HIV-related TB and silicotuberculosis, but global uptake has been poor. We describe the design of a cluster randomised study, "Thibela TB", which compares routine IPT targeted to those identified as at higher risk of TB (due to HIV infection or silicosis) against a "community-wide" approach in which IPT is offered to all employees. The trial is registered with the Current Controlled Trials: Registration number ISRCTN63327174. Methods: We describe the rationale for the intervention of community-wide IPT, drawing on studies conducted in 1950-1960s in the pre-HIV era. The design of the study, including the definition of the cluster, is presented and advantages and limitations of such a design are discussed. Conclusion: If successful in reducing TB incidence and prevalence, this trial has potential to make a major contribution to TB control policy in high HIV settings, providing evidence concerning efficacy, and additionally safety and population-level effects on drug susceptibility patterns. Such rigorous evaluation is essential to provide policy makers with an evidence base to guide community-level TB prevention strategies.

Original languageEnglish (US)
Pages (from-to)382-392
Number of pages11
JournalContemporary Clinical Trials
Volume32
Issue number3
DOIs
StatePublished - May 2011

Fingerprint

Isoniazid
South Africa
Gold
Tuberculosis
HIV
Therapeutics
Silicotuberculosis
Miners
Silicosis
Administrative Personnel
Dust
Silicon Dioxide
HIV Infections
Safety
Incidence

Keywords

  • Cluster randomised
  • Isoniazid
  • South Africa
  • Tuberculosis

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Medicine(all)

Cite this

Thibela TB : Design and methods of a cluster randomised trial of the effect of community-wide isoniazid preventive therapy on tuberculosis amongst gold miners in South Africa. / Fielding, Katherine L.; Grant, Alison D.; Hayes, Richard J.; Chaisson, Richard E; Corbett, Elizabeth L.; Churchyard, Gavin J.

In: Contemporary Clinical Trials, Vol. 32, No. 3, 05.2011, p. 382-392.

Research output: Contribution to journalArticle

Fielding, Katherine L. ; Grant, Alison D. ; Hayes, Richard J. ; Chaisson, Richard E ; Corbett, Elizabeth L. ; Churchyard, Gavin J. / Thibela TB : Design and methods of a cluster randomised trial of the effect of community-wide isoniazid preventive therapy on tuberculosis amongst gold miners in South Africa. In: Contemporary Clinical Trials. 2011 ; Vol. 32, No. 3. pp. 382-392.
@article{7a63f8ccf9514a91b42efbad2fa70765,
title = "Thibela TB: Design and methods of a cluster randomised trial of the effect of community-wide isoniazid preventive therapy on tuberculosis amongst gold miners in South Africa",
abstract = "Background: South Africa has the third highest annual number of new tuberculosis (TB) cases globally. The resurgence of TB which has particularly affected gold miners in South Africa, is attributed to occupational risk factors for TB including silica dust exposure and high HIV prevalence. Isoniazid preventive therapy (IPT) is recommended for individuals at high risk to prevent both HIV-related TB and silicotuberculosis, but global uptake has been poor. We describe the design of a cluster randomised study, {"}Thibela TB{"}, which compares routine IPT targeted to those identified as at higher risk of TB (due to HIV infection or silicosis) against a {"}community-wide{"} approach in which IPT is offered to all employees. The trial is registered with the Current Controlled Trials: Registration number ISRCTN63327174. Methods: We describe the rationale for the intervention of community-wide IPT, drawing on studies conducted in 1950-1960s in the pre-HIV era. The design of the study, including the definition of the cluster, is presented and advantages and limitations of such a design are discussed. Conclusion: If successful in reducing TB incidence and prevalence, this trial has potential to make a major contribution to TB control policy in high HIV settings, providing evidence concerning efficacy, and additionally safety and population-level effects on drug susceptibility patterns. Such rigorous evaluation is essential to provide policy makers with an evidence base to guide community-level TB prevention strategies.",
keywords = "Cluster randomised, Isoniazid, South Africa, Tuberculosis",
author = "Fielding, {Katherine L.} and Grant, {Alison D.} and Hayes, {Richard J.} and Chaisson, {Richard E} and Corbett, {Elizabeth L.} and Churchyard, {Gavin J.}",
year = "2011",
month = "5",
doi = "10.1016/j.cct.2010.12.008",
language = "English (US)",
volume = "32",
pages = "382--392",
journal = "Contemporary Clinical Trials",
issn = "1551-7144",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Thibela TB

T2 - Design and methods of a cluster randomised trial of the effect of community-wide isoniazid preventive therapy on tuberculosis amongst gold miners in South Africa

AU - Fielding, Katherine L.

AU - Grant, Alison D.

AU - Hayes, Richard J.

AU - Chaisson, Richard E

AU - Corbett, Elizabeth L.

AU - Churchyard, Gavin J.

PY - 2011/5

Y1 - 2011/5

N2 - Background: South Africa has the third highest annual number of new tuberculosis (TB) cases globally. The resurgence of TB which has particularly affected gold miners in South Africa, is attributed to occupational risk factors for TB including silica dust exposure and high HIV prevalence. Isoniazid preventive therapy (IPT) is recommended for individuals at high risk to prevent both HIV-related TB and silicotuberculosis, but global uptake has been poor. We describe the design of a cluster randomised study, "Thibela TB", which compares routine IPT targeted to those identified as at higher risk of TB (due to HIV infection or silicosis) against a "community-wide" approach in which IPT is offered to all employees. The trial is registered with the Current Controlled Trials: Registration number ISRCTN63327174. Methods: We describe the rationale for the intervention of community-wide IPT, drawing on studies conducted in 1950-1960s in the pre-HIV era. The design of the study, including the definition of the cluster, is presented and advantages and limitations of such a design are discussed. Conclusion: If successful in reducing TB incidence and prevalence, this trial has potential to make a major contribution to TB control policy in high HIV settings, providing evidence concerning efficacy, and additionally safety and population-level effects on drug susceptibility patterns. Such rigorous evaluation is essential to provide policy makers with an evidence base to guide community-level TB prevention strategies.

AB - Background: South Africa has the third highest annual number of new tuberculosis (TB) cases globally. The resurgence of TB which has particularly affected gold miners in South Africa, is attributed to occupational risk factors for TB including silica dust exposure and high HIV prevalence. Isoniazid preventive therapy (IPT) is recommended for individuals at high risk to prevent both HIV-related TB and silicotuberculosis, but global uptake has been poor. We describe the design of a cluster randomised study, "Thibela TB", which compares routine IPT targeted to those identified as at higher risk of TB (due to HIV infection or silicosis) against a "community-wide" approach in which IPT is offered to all employees. The trial is registered with the Current Controlled Trials: Registration number ISRCTN63327174. Methods: We describe the rationale for the intervention of community-wide IPT, drawing on studies conducted in 1950-1960s in the pre-HIV era. The design of the study, including the definition of the cluster, is presented and advantages and limitations of such a design are discussed. Conclusion: If successful in reducing TB incidence and prevalence, this trial has potential to make a major contribution to TB control policy in high HIV settings, providing evidence concerning efficacy, and additionally safety and population-level effects on drug susceptibility patterns. Such rigorous evaluation is essential to provide policy makers with an evidence base to guide community-level TB prevention strategies.

KW - Cluster randomised

KW - Isoniazid

KW - South Africa

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=79953033520&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953033520&partnerID=8YFLogxK

U2 - 10.1016/j.cct.2010.12.008

DO - 10.1016/j.cct.2010.12.008

M3 - Article

VL - 32

SP - 382

EP - 392

JO - Contemporary Clinical Trials

JF - Contemporary Clinical Trials

SN - 1551-7144

IS - 3

ER -